Jamie Christensen - Dec 3, 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 3, 2021
Transactions value $
-$157,078
Form type
4
Date filed
12/7/2021, 04:52 PM
Previous filing
May 25, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +6.86K +12.73% $0.00 60.7K Dec 3, 2021 Direct F1
transaction MRTX Common Stock Sale -$156K -1.19K -1.96% $130.78 59.5K Dec 6, 2021 Direct F2
transaction MRTX Common Stock Sale -$1.19K -9 -0.02% $132.00 59.5K Dec 6, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 50% of the PSUs have vested on December 3, 2021 (the "Achievement Date"), and the remaining 50% shall vest on the one-year anniversary of the Achievement Date, subject to Dr. Christensen's continuous service.
F2 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.